Biomarkers may help predict risk of Alzheimer's disease in patients with mild cognitive impairment
Tuesday, July 21, 2009 - 16:28
in Health & Medicine
Several cerebrospinal fluid (CSF) biomarkers showed good accuracy in identifying patients with mild cognitive impairment who progressed to Alzheimer disease, according to a study in the July 22/29 issue of JAMA.